Idexx Laboratories (IDXX) Profit Margin (2009 - 2026)
Idexx Laboratories (IDXX) profit margin from Jun 30, 2009 to Mar 31, 2026. The current Idexx Laboratories (IDXX) profit margin is 24.41%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Idexx Laboratories (IDXX)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 24.62% | +8.06% |
| 2024 | 22.78% | -1.31% |
| 2023 | 23.08% | +14.46% |
| 2022 | 20.17% | -12.94% |
| 2021 | 23.17% | +7.77% |
| 2020 | 21.49% | +20.96% |
| 2019 | 17.77% | +4.32% |
| 2018 | 17.04% | -0.36% |
| 2018 | 17.10% | -8.65% |
| 2018 | 18.72% | +12.49% |
| 2018 | 16.64% | +24.49% |
| 2017 | 13.36% | -6.76% |
| 2017 | 14.33% | -14.55% |
| 2017 | 16.77% | +12.27% |
| 2017 | 14.94% | +19.44% |
| 2016 | 12.51% | -0.69% |
| 2016 | 12.59% | -12.56% |
| 2016 | 14.40% | +30.68% |
| 2016 | 11.02% | -8.08% |
| 2015 | 11.99% | +10.20% |
| 2015 | 10.88% | -20.97% |
| 2015 | 13.77% | +13.03% |
| 2015 | 12.18% | -0.51% |
| 2014 | 12.24% | -9.94% |
| 2014 | 13.60% | -7.31% |
| 2014 | 14.67% | +13.40% |
| 2014 | 12.93% | -5.16% |
| 2013 | 13.64% | +0.98% |
| 2013 | 13.51% | -11.82% |
| 2013 | 15.32% | +13.39% |
| 2013 | 13.51% | -2.00% |
| 2012 | 13.78% | +1.48% |
| 2012 | 13.58% | -11.17% |
| 2012 | 15.29% | +21.10% |
| 2012 | 12.63% | -4.90% |
| 2011 | 13.28% | +3.75% |
| 2011 | 12.80% | -16.41% |
| 2011 | 15.31% | +22.38% |
| 2011 | 12.51% | -2.31% |
| 2010 | 12.80% | -0.48% |
| 2010 | 12.87% | -2.62% |
| 2010 | 13.21% | +7.41% |
| 2010 | 12.30% | +3.82% |
| 2009 | 11.85% | +4.44% |
| 2008 | 11.34% | N/A |
Comparison Idexx Laboratories (IDXX) profit margin with competitors
Idexx Laboratories (IDXX) profit margin is 24.41%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| VCYT | Veracyte Inc | 20.64% | -15.44% |
| QGEN | Qiagen NV | 20.33% | -16.71% |
| MTD | Mettler-Toledo International Inc | 17.89% | -26.70% |
| MEDP | Medpace Holdings Inc | 17.53% | -28.18% |
| DHR | Danaher Corp | 17.29% | -29.16% |
| A | Agilent Technologies Inc | 16.96% | -30.51% |
| BLLN | Billiontoone Inc - Class A | 16.58% | -32.07% |
| TMO | Thermo Fisher Scientific Inc | 15.00% | -38.54% |
| ILMN | Illumina Inc | 12.28% | -49.69% |
| SHC | Sotera Health Company | 9.49% | -61.12% |
| DGX | Quest Diagnostics Inc | 8.70% | -64.36% |
| LH | Laboratory Corp Of America Holdings | 7.85% | -67.84% |
| IQV | IQVIA Holdings Inc | 6.60% | -72.96% |
| FONR | Fonar Corp | 6.20% | -74.60% |
| RVTY | Revvity Inc | 5.73% | -76.52% |
| CDNA | Caredx Inc | 2.39% | -90.21% |